Interleukin-8 (IL-8) is a major neutrophil chemotaxin from human alveolar macrophages stimulated with staphylococcal enterotoxin A (SEA)

Inflammation Research

Volumn 45, Issue 8, 1996, Pages 386-392

  Miller, E J ^a   Nagao, S ^c   Carr, F K ^a   Noble, J M ^a   Cohen, A B ^a,b  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b Health Science Center   (United States)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Inflammation; Interleukin 8; Macrophages; Neutrophils; Staphylococcal enterotoxin A

Indexed keywords

CHEMOTAXIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 8; MESSENGER RNA; MONOCLONAL ANTIBODY; STAPHYLOCOCCUS ENTEROTOXIN A;

ARTICLE; CELL MATURATION; CELL SECRETION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; MONOCYTE; NEUTROPHIL CHEMOTAXIS;

EID: 0029784580     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02252933     Document Type: Article

References (49)

1. Ostroff RM, Vasil AI, Vasil ML. Molecular comparison of a nonhemolytic and hemolytic phospholipase C from Pseudomonas aeruginosa. J Bacteriol 1990;172:5915-23.
2. Bhakdi S, Tranum-Jensen J. Alpha-toxin of staphylococcus aureus. Microbiol Rev 1991;55:733-51.
3. Brigham KL, Bowers RE, Haynes J. Increased sheep lung vascular permeability caused by Eschericia coli endotoxin. Circ Res 1979:45:292-7.
4. Rinaldo JE, Dauber JH, Christman J, Rogers RM. Neutrophil alveolitis following endotoxemia. Am Rev Respir Dis 1984;130:1065-71.
5. Bachofen M, Weibel ER. Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicaemia. Am Rev Respir Dis 1977;116:589-615.
6. Weiland JE, Davis WB, Holter JF, Mohammed JR, Dorinsky PM, Gadek JE. Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathological significance. Am Rev Respir Dis. 1986;133:218-25.
7. Miller EJ, Cohen AB, Nagao S, Griffith DE, Maunder RJ, Martin TR, et al. Elevated levels of NAP-1/Interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 1992;146:427-32.
8. Kunkel SL, Standiford T, Kasahara K, Stricter RM. Interleukin-8 (IL-8): The major neutrophil chemotactic factor in the lung. Exp Lung Res 1991;17:17-23.
9. Yoshimura T, Matsushima K, Oppenheim JJ, Leonard EJ. Neutrophil chemotactic factor produced by lipopolysaccharide LPS-stimulated human blood mononuclear leukocytes: Partial characterization and separation from interleukin 1 (II-1). J Immunol 1987;139:788-93.
10. Stricter RM, Chensue SW, Basha MA, Standiford TJ, Lynch JP, Baggiolini M., et al. Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-alpha, lippoolysaccharide, and interleukin-1 beta. Am J Respir Cell Mol Biol 1990;2:321-6.
11. Standiford TJ, Kunkel SL, Basha MA, Chensue SW, Lynch JP, Toews G.B., et al. Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J Clin Invest 1990;86:1945-53.
12. Griffith DE, Miller EJ, Gray LD, Idell S, Johnson AR. Interleukin-1-mediated release of Interleukin-8 by asbestos-stimulated human pleural mesothelial cells. Am J Resp Cell Mol Biol 1994;10:245-52.
13. Walz A, Peveri P, Aschauer H, Baggiolini M. Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. Biochem Biophys Res Commun 1987;149:755-61.
14. Willems J, Joniau M, Cinque S, Van Damme J. Human granulocyte chemotactic peptide (Il-8) as a specific degranulator: comparison with other monokines. Immunology 1989;67:540-2.
15. Thelen M, Peveri P, Kernen P, von Tscharner V, Walz A, Baggiolini M. Mechanism of neutrophil activation by NAF, a novel monocyte-derived peptide agonist. FASEB J 1988;2:2702-6.
16. Peveri P, Walz A, DeWald B, Baggiolini M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med 1988;167:1547-59.
17. Idell S, Kucich U, Fein A, Kueppers F, James HL, Walsh PN, et al. Neutrophil elastase-releasing factors in bronchoalveolar lavage from patients with adult respiratory distress syndrome. Am Rev Respir Dis 1985;132:1098-105.
18. Shasby DM, Vanbenthuysen KM, Tate RM, Shasby SS, McMurty I, Repine JE. Granulocytes mediate acute edematous lung injury in rabbits and in isolated rabbit lungs perfused with phorbol myristate acetate: Role of oxygen radicals. Am Rev Respir Dis 1982;125:443-7.
19. Horan TC, White JW, Jarvis WR, Emori TG, Culber DH, Munn VP, et al. Nosocomial infection surveillance. Morbid Mortal Weekly 1986;35:17SS-29.
20. Musher DM, McKenzie SO. Infections due to staphylococcus aureus. Medicine 1977;56:383-409.
21. Bell RC, Coalson JJ, Smith JD, Johanson WG. Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med 1983;99:293-8.
22. Johnson HM, Russelland JK, Pontzer CH. Staphylococcal enterotoxin microbial superantigens. FASEB J 1991;5:2706-12.
23. Grossman D, Cook RG, Sparrow JT, Mollick JA, Rich RR. Dissociation of the stimulatory activities of staphylococcal enterotoxins for T cells and monocytes. J Exp Med 1990;172:1831-41.
24. Johnson HM, Russell JK, Pontzer CH. Staphylococcal enterotoxin superantigens. PSEBM 1991;198:765-71.
25. Huang I.-Y, Hughes JL, Bergdoll MS, Schantz EJ. Complete amino acid sequence of staphylococcal enterotoxin A. J Biol Chem 1987;262:7006.
26. Carlsson R, Fischer H, Sjogren H-O. Binding of staphylococcal enterotoxin A to accessory cells is a requirement for its ability to activate human T cells. J Immunol 1992;140:2484-8.
27. Langford MP, Stanton GJ, Johnson HM. Biological effects of Staphylococcal entertoxin A on peripheral lymphocytes. Infect Immun 1978;22:62-6.
28. Sundstrom C, Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 1976;17:565-77.
29. Evans R, Kamdar SJ. Stability of RNA isolated from macrophages depends on the removal of an RNA-degrading activity early in the extraction procedure. BioTechn 1990;8: 357-60.
30. Maniatis T, Fritsch EF, Sambrook J. Extraction, purification, and analysis of mRNA from eukaryotic cells. In: Molecular cloning: A laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory, 1982:187-210.
31. Kowalski J, Denhardt DT. Regulation of the mRNA for MONAP, an inflammatory response monokine, in differentiating HL60 promyelocytes. Mol Cell Biol 1989;9:1946-57.
32. Sylvester I, Rankin JA, Yoshimura T, Tanaka S, Leonard EJ. Secretion of neutrophil attractant/activation protein by lipopolysaccharide-stimulated lung macrophages determined by both enzyme-linked immunosorbent assay and N-terminal sequence analysis. Am Rev Resp Dis 1990;141:683-8.
33. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at 1 xg. Scand J Clin Lab Invest 1968;21 Suppl 97:77-99.
34. Cohen AB, Chenoweth DE, Hugli TE. The release of elastase and other enzymes from human alveolar macrophages. Am Review Resp Dis 1982;126:241-7.
35. MacArthur CK, Miller EJ, Cohen AB. A peptide secreted by human alveolar macrophages which releases neutrophil granule contents. J Immunol 1987;139:3456-62.
36. Cohen AB, MacArthur C, Idell S, Maunder R, Martin T, Dinarello C., et al. A peptide from alveolar macrophages that releases neutrophil enzymes into the lungs in patients with Adult Respiratory Distress Syndrome. Am Rev Resp Dis 1988;137:1151-8.
37. Zigmond S, Hirsch J. Leukocyte locomotion and chemotaxis. J Exp Med 1973;137:387-410.
38. Snyderman R, Pyke MC. Chemotaxis of mononuclear cells. In: Bloom BR, David JR, editors. In vitro methods in cell mediated and tumor immunity. New York: Academic Press, 1976:651-61.
39. Fowler AA, Hamman RF, Good JT, Benson B, David B, Eberke D, et al. Adult respiratory distress syndrome: Risk with common predispositions. Ann Intern Med 1983;98:593-7.
40. Pepe PE, Potkin RT, Reus DH, Hudson CD, Carrico CJ. Clinical predictors of the adult respiratory distress syndrome. Am J Surg 1982;144:124-30.
41. Weinberg PF, Matthay MA, Webster RO, Roskos KV, Goldstein IM, Murray JF. Biologically active products of complement and acute lung injury in patients with the sepsis syndrome. Am Rev Respir Dis 1984;130:791-6.
42. Mongomery AB, Stager MA, Carrico CJ, Hudson LD. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1985;132:485-9.
43. Seidenfeld JJ, Pohl DF, Bell RC, Harris GD, Johanson Jr WG. Incidence, site, and outcome of infections in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1986;134:12-6.
44. Bjork L, Andersson J, Ceska M, Andersson . Endotoxin and staphylococcus aureus enterotoxin A induce different patterns of cytokines. Cytokine 1992;4:513-9.
45. Miller EJ, Carr FK, Blumenthal DK, Cohen AB. Neutrophil activating factor (NAF) is secreted by human alveolar macrophages in the absence of added stimuli. J Cell Biol 1988;107:58a.
46. Kasahara K, Stricter RM, Chensue SW, Standiford TJ, Kunkel SL. Mononuclear cell adherence induces neutrophil chemotactic factor/interleukin-8 gene expression. J Leuk Biol 1991;50:287-95.
47. Magnusson KE, Wojcieszyn J, Dahlgren C, Stendahl O, Sundqvist T, Jacobson K. Lateral diffusion of wheat germ agglutinin-labeled glycoconjugates in the membrane of differentiating HL-60 and U-937 cells assessed with fluorescence recovery after photobleaching (FRAP). Cell Biophys 1983;5:119-28.
48. Miller EJ, Cohen AB, Matthay MA. Elevated Interleukin-8 levels in pulmonary edema fluid of patients with ARDS from sepsis. Crit Care Med. In press.
49. Kurdowska A, Miller EJ, Cohen AB. An anti-interleukin-8 monoclonal antibody that interferes with the binding of interleukin 8 to cellular receptors and the activation of human blood neutrophils. Hybridoma 1995;14:225-33.